Clinical Trial Update: A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for Pegerythropoietin Injection (RD01) in anemia due to chronic renal failure in hemodialysis patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia in Chronic Renal Failure with Hemodialysis

Drugs mentioned

• Pegerythropoietin Injection (RD01) (null)

Snippet

Sponsor: Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd | Conditions: Patient of Anemia in Chronic Renal Failure With Hemodialysis | Phase 2 | Status: UNKNOWN